Concepedia

CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases

Nicholas Figura, T. Potluri, Homan Mohammadi, Daniel Oliver, John A. Arrington, Timothy J. Robinson, Arnold B. Etame, Nam Tran, James K. Liu, Hatem Soliman,

Journal of Neuro-Oncology · 2019 · 69 citations · 30 references

DOI

Concepts

References

30

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn, Miguel Martín, Hope S. Rugo et al. · New England Journal of Medicine · 2016 · 2.9K citations

, , +17

Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases

Hidefumi Aoyama, Hiroki Shirato, Masao Tago et al. · JAMA · 2006 · 2.2K citations

, , +17

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Richard S. Finn, John Crown, István Láng et al. · The Lancet Oncology · 2014 · 1.9K citations

, , +17

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Matthew P. Goetz, Masakazu Toi, Mario Campone et al. · Journal of Clinical Oncology · 2017 · 1.7K citations · Full text

, , +16

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

Edward Shaw, Charles Scott, Luís Souhami et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.6K citations

, , +10